MCRIP2P2

Across TCGA pan-cancer cohorts, MCRIP2P2 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated MCRIP2P2 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MCRIP2P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MCRIP2P2 expression acts as an unfavorable survival marker.

STAD, SKCM, and KIRC are the cancer types where MCRIP2P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	II,III,IV	0.413	0.736	<.001	135	view →
SKCM	OS	Tertile	All	0.255	0.789	<.001	66	view →
KIRC	DFS	Tertile	IV	0.205	0.603	.001	54	view →
BLCA	DFS	Tertile	All	0.236	0.630	.001	54	view →
LIHC	OS	Tertile	All	0.188	0.690	.005	45	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
UCEC	DFS	Tertile	All	0.308	0.651	.003	18	view →
LAML	DFS	Tertile	All	0.159	0.493	.008	18	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

MCRIP2P2–STAD (OS)

Open the STAD breakdown →